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Summary: Several gene-based association tests for time-to-event traits have been proposed recently, to detect
whether a gene region (containing multiple variants), as a set, is associated with the survival outcome. However,
for bivariate survival outcomes, to the best of our knowledge, there is no statistical method that can be directly
applied for gene-based association analysis. Motivated by a genetic study to discover gene regions associated with the
progression of a bilateral eye disease, Age-related Macular Degeneration (AMD), we implement a novel functional
regression method under the copula framework. Specifically, the effects of variants within a gene region are modeled
through a functional linear model, which then contributes to the marginal survival functions within the copula.
Generalized score test and likelihood ratio test statistics are derived to test for the association between bivariate
survival traits and the genetic region. Extensive simulation studies are conducted to evaluate the type-I error control
and power performance of the proposed approach, with comparisons to several existing methods for a single survival
trait, as well as the marginal Cox functional regression model using the robust sandwich estimator for bivariate
survival traits. Finally, we apply our method to a large AMD study, the Age-related Eye Disease Study (AREDS),
to identify gene regions that are associated with AMD progression. The method has been implemented and added
into a newly developed R package {CopulaCenR}.
Key words: AMD progression; Bivariate time-to-event; Copula; Functional Regression; Gene-based association
analysis.
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1. Introduction
In genome-wide association studies (GWAS), single variant test is useful in detecting signif-
icant SNPs across the whole genome. Typically, after top loci are detected and confirmed in
replication studies, regions around top variants will then be fine-mapped to further evaluate
the disease loci. However, there are limitations of single variant tests. First, with each SNP
been tested individually, it may suffer from issues such as lack of power and multiple testing
adjustment. Secondly, the true causal SNP may not be genotyped due to the technology
or cost reason. Instead, a SNP that is close to the true causal variant is often captured.
With partial linkage disequilibrium (LD), the observed effect size is likely to be smaller.
Furthermore, most statistical approaches used for single variant test focus on common
variants and can be too liberal for rare variants with low minor allele frequency (MAF).
A threshold for MAF (e.g., > 5%) is commonly applied when performing GWAS on single
variants. To solve these problems, there has been increasing interests in developing gene-
based tests in genetic association analysis, which can usually take the LD information within
a region into account and are suitable for collapsing a set of variants with low MAF.
The statistical methods for gene-based association studies can be broadly classified as
burden tests, kernel-based association tests and functional-regression-based methods. Burden
test was first proposed by Li and Leal (2008) for binary traits to detect association with
rare variants for common diseases. The general idea of burden test is based on collapsing
rare variants in a genetic region to a summary variable, which is then used for testing the
association with the phenotype. Han and Pan (2010) extended the burden test to the censored
time-to-event traits under Cox proportional hazards (PH) framework and Chien et al. (2017)
further developed burden test for survival traits in family-based designs. Traditional burden
test suffers from the lack of power when heterogeneous genetic effects exist within a region,
therefore several adaptive approaches have been proposed recently. For example, Wu et al.
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(2018) proposed to use mixed-model tests to make full use of genetic correlations across
both samples and variants, and to gain power through “data-driven” weights which are
adaptive to the direction of individual variant’s effect. Another popular approach is the
sequence kernel association test (SKAT), proposed by Wu et al. (2011). It is considered as a
computationally efficient score test on variance component parameter to test for association
between genetic variants in a region and different types of traits. In 2014, Chen et al. (2014)
proposed the SKAT tests for survival traits in a Cox PH regression framework. One advantage
of SKAT is that it can quickly calculate p-values by fitting the null model containing only
the non-genetic covariates. A common limitation of the burden test and SKAT is the lack
of effectively utilizing the LD information or in other words, correlations among genetic
variants. Fan et al. (2013) first introduced the idea of functional regression (FR) for testing
associations between genetic variants and quantitative traits. The FR-based model treats
the effect of genetic variants as an unknown function of variants’ actual physical positions
in a functional linear model (FLM) and utilizes the LD information among close variants. It
has been shown that for continuous, binary and censored traits, the FLM approach can be
more powerful than SKAT or burden test in various scenarios (Fan et al. 2013, 2014, 2016).
This work is motivated by a genetic study for Age-related Macular Degeneration (AMD)
to identify risk regions associated with AMD progression. AMD, a leading cause of blind-
ness in the developed world (Swaroop et al. 2009; The Eye Diseases Prevalence Research
Group 2004), is a bilateral and progressive neurodegenerative disease. Recently, multiple
studies have been conducted to underpin the genetic causes for disease progression where
the outcome of interest is the bivariate time-to-progression (e.g., time-to-late-AMD of the
two affected eyes). For example, Sardell et al. (2016) and Ding et al. (2017) analyzed a
small set of variants on AMD progression using a Cox PH model with the robust variance
covariance estimate that takes the between-eye correlation into account. More recently, Yan
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et al. (2018) performed the first GWAS on AMD progression using a similar robust Cox
PH model. Multiple risk loci have been identified to be associated with AMD progression.
However, in all these studies, the focus is on common variants with MAF > 5%. In this
work, instead of evaluating the effect of single (common) variants on AMD progression, we
are interested in identifying and assessing the gene regions associated with AMD progression.
To our knowledge, there has been only one attempt so far on gene-based analysis for AMD
progression, done by Fan et al. (2016). They applied the FR-based approach under the Cox
PH model by using the left eye information only, due to the lack of methods for bivariate
survival traits in gene-based analysis.
Bivariate or multivariate survival analysis has been studied for decades. Thorough reviews
with examples can be obtained from Joe (1997) and Hougaard (2000). The Copula family
is one of the earliest approaches for modeling bivariate survival data (Clayton 1978). The
idea is to model the joint distribution as a function of each marginal distribution together
with a dependence parameter. Another popular approach for correlated survival data is the
frailty model, of which the correlation is modeled through a common latent frailty variable
(Oakes 1982). The third approach is a marginal method (Wei et al. 1989) such as the robust
Cox model used in Ding et al. (2017) and Yan et al. (2018), of which the variance-covariance
matrix is estimated from a robust sandwich estimator.
In this work, we propose to develop and implement a novel gene-based association analysis
method for bivariate survival traits based on functional regression under the copula frame-
work. The paper is organized as follows. Section 2 introduces the proposed copula-based
FLM method. Section 3 presents simulation studies for evaluating type-I error control and
power performance under various settings. Section 4 demonstrates a real data analysis on
AMD progression using the proposed method, and followed by the discussion of practical
challenges and possible extensions in Section 5.
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2. Method
2.1 Copula model for bivariate time-to-event data
One of the earliest distribution families for modeling correlated bivariate measurements is
the copula family (Clayton 1978), originated from Sklar’s Theorem (Sklar 1959), in which
the joint distribution is modeled as a function of each marginal distribution together with a
dependence parameter. Assume U and V are both uniformly distributed random variables,
then a bivariate copula is a function defined as {Cη : [0, 1]2 → [0, 1] : (u, v) → Cη(u, v), η ∈
R}. The parameter η in the copula function describes the dependence between U and V .
By the Sklar’s theorem (Sklar 1959), one can model the joint distribution by modeling the
dependence parameter and the marginal distributions separately. This is the unique feature
of copula functions that makes them attractive to use. The theorem is stated as: if marginal
survival functions S1(t1) = P (T1 > t1) and S2(t2) = P (T2 > t2) for T1 and T2 are continuous,
then there exists a unique copula function Cη such that for all t1 > 0, t2 > 0, the joint
survival function S(t1, t2) can be written as
S(t1, t2) = Cη((S1(t1), S2(t2)), t1, t2 > 0. (2.1)
Define the density function for Cη to be cη = ∂
2Cη(u, v)/∂ u∂ v, then the joint density
function of T1 and T2 can be expressed as
f(t1, t2) = cη(S1(t1), S2(t2))f1(t1)f2(t2), t1, t2 > 0.
In this work, we choose to use the Archimedean copula family, which is one of the most
popular copula families because of its flexibility and simplicity. For example, the rank-
based dependence measurement Kendall’s τ can be directly obtained as a function of η
in Archimedean copula models. Two most frequently used Archimedean copulas in survival
analysis are:
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Clayton copula (Clayton 1978)
Cη(u, v) = (u
−η + v−η − 1)−1/η, η ∈ (0,∞),
which models the lower tail dependence in survival functions; and
Gumbel-Hougaard copula (Gumbel 1960)
Cη(u, v) = exp{−[(− log u)η + (− log v)η]1/η}, η ∈ [1,∞),
which models the upper tail dependence in survival functions.
We consider modeling the margins S1(·) and S2(·) inside the copula function using the Cox
PH model, within which the effect of a gene region (captured by multiple single variants) is
modeled through a FLM, as we describe below.
2.2 Functional Linear Model Specification
Assume n individuals with m variants being sequenced for a gene region. Physical positions
for each variant within that region are denoted as 0 6 u1 < · · · < um (which are typically
standardized into [0, 1]). Let Gi = (gi(u1), . . . , gi(um))
′, gi(uj) ∈ (0, 1, 2), i = 1, . . . , n, j =
1, . . . ,m, denote the genotype information for the m variants of subject i, indicating the
number of copies of the minor allele for each of these m variants. Let
(X1i, X2i) = ((x1i1, . . . , x1ip), (x2i1, . . . , x2ip)),
denote a p× 2 matrix of bivariate covariates for subject i. Then the hazard function for the
kth margin (k = 1, 2) under the PH-FLM can be written as
λki(t) = λk0(t) exp
(
X ′kiβ +
∫ 1
0
Gi(u)γ(u)du
)
,
where λk0(t) is the baseline hazard function for the kth margin, β is a p × 1 vector of
coefficients for the non-genetic covariates, and γ(u) is the genetic effect function of the
genetic variant function Gi(u) at position u. We assume both γ(u) and Gi(u) are smooth
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functions. Then the corresponding marginal survival functions are
Ski(t) = exp(−Λki(t)) = exp
(
−
∫
λki(t)dt
)
= exp
(
−
∫
λk0(t) exp
(
X ′kiβ +
∫ 1
0
Gi(u)γ(u)du
)
dt
)
, k = 1, 2.
Next, we describe how we handle the two functions Gi(u) and γ(u), respectively.
2.2.1 The genetic variant function (GVF) Gi(u). If the genotype data are of good quality
with low missing rate, we can simply use the observed genetic information to represent the
GVF directly, such as Gˆi(u) = Gi = (gi(u1), . . . , gi(um)). In this case, the elements of Gˆi(u)
take discrete values 0, 1, 2.
If the genotype data have a fairly high missing rate or equivalent, the region has only a
small number of variants being genotyped, one may consider applying an ordinary linear
square smoother (Ramsay et al. 2009) to obtain a continuous realization of Gi. Let φ(u) =
(φ1(u), . . . , φBG(u))
′ be a series of basis functions (e.g, B-spline or Fourier spline basis).
Denote by Φ the m × BG matrix with elements φb(uj), b = 1, . . . , BG, j = 1, . . . ,m. Then
through a linear square smoother, an estimate of the GVF can be written as
Gˆi(u) = (gi(u1)), . . . , gi(um))Φ[Φ
′Φ]−1φ(u). (2.2)
Under the situation with missing data, we have
Gˆi(u) = (gi(u1)), . . . , gi(um′))Φ˜[Φ˜
′Φ˜]−1φ(u),
where (gi(u1)), . . . , gi(um′)) are the observed non-missing genotypes and Φ˜ is the correspond-
ing basis matrix evaluated at the non-missing genotypes.
2.2.2 The genetic effect function (GEF) γ(u). The GEF γ(u) is an unknown smooth
function with an arbitrary form that we need to estimate. To do this, one can approximate
it using a sieve approach with a linear combination of basis functions and coefficients. Define
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a series of Bγ basis function by ψ(u) = (ψ1(u), . . . , ψBγ (u))
′ and a Bγ × 1 vector γ =
(γ1, . . . , γBγ )
′, then γ(u) can be approximated by
γˆ(u) = (ψ1(u), . . . , ψBγ (u))(γ1, . . . , γBγ )
′. (2.3)
To test whether the variants in a region, as a set, is associated with the outcome, it is to test
whether the GEF is a zero function γ(u) = 0, which is equivalent to test the null hypothesis:
H0 : γ1 = · · · = γBγ = 0. Typically, the number of basis Bγ is much smaller than the number
of variants m in the region being tested.
2.2.3 The hazard function λ(t) under the FLM. Depending on whether or not to smooth
the GVF G(u), we propose two types of functional regression models for the hazard function.
The first option is to smooth both G(u) and γ(u). By replacing G(u) and γ(u) with their
approximated values in (2.2) and (2.3), the hazard function for each margin can be written
as
λki(t) = λk0(t) exp
(
X ′kiβ + (gi(u1), . . . , gi(um))Φ[Φ
′Φ]−1γ
∫ 1
0
φ(u)ψ(u)du
)
(2.4)
= λk0(t) exp(X
′
iβ +M
′
iγ),
where M ′i = (gi(u1), . . . , gi(um))Φ[Φ
′Φ]−1
∫ 1
0
φ(u)ψ(u)du. The integral
∫ 1
0
φ(u)ψ(u)du can be
readily calculated using the R package {fda} (Ramsay et al. 2009) once the basis functions
are chosen.
Another option is to smooth γ(u) only. In this case, we directly replace Gi(u) by the
observed Gi = (gi(u1), ..., gi(um))
′ and replace γ(u) by (2.3), which yields
λki(t) = λk0(t) exp
(
X ′kiβ +
[
m∑
j=1
(gi(uj)× (ψ1(uj), . . . , ψBγ (uj))
]
(γ1, . . . , γBγ )
′
)
(2.5)
= λk0(t) exp(X
′
iβ +M
′
iγ),
where M ′i =
∑m
j=1 gi(uj)× (ψ1(uj), . . . , ψBγ (uj)) is a fully observed term.
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Two frequently used basis functions are B-splines and Fourier splines. The B-spline basis
(de Boor 2011) is a series of non-periodic functions with polynomial segments joint at values
called knots. The segments have specifiable smoothness across every breaks. Advantages of
applying the B-spline basis include its fast computation and great flexibility in structure. The
Fourier splines consist of a set of periodic functions, with the basis function being Φ1(u) = 1,
Φ2r(u) = cos(2piru) and Φ2r+1(u) = sin(2piru) for a pre-specified r (de Boor 2011).
2.3 Bivariate FLM under the copula framework
Let (T1i, T2i) and (C1i, C2i) denote the bivariate survival times and censoring times for subject
i, respectively. Denote by ∆i = (∆1i,∆2i) the corresponding censoring indicator. We consider
right censoring and assume that given covariates, (T1, T2) and (C1, C2) are independent. Then
for each subject, we observe
Di = {(Y1i, Y2i,∆1i,∆2i, X1i, X2i, Gi) : Yki = min(Tki, Cki),∆ki = I(Tki 6 Cki), k = 1, 2}.
Denote by θ all the parameters in S(t1, t2), then the joint likelihood for the observed data
{Di}ni=1 can be written as
L(θ;D = (Y1, Y2,∆1,∆2, X1, X2, G))
=
n∏
i=1
f(y1i, y2i)
δ1iδ2i ×
[
−∂S(y1i, y2i)
∂y1i
]δ1i(1−δ2i)
×
[
−∂S(y1i, y2i)
∂y2i
](1−δ1i)δ2i
× S(y1i, y2i)(1−δ1i)(1−δ2i),
(2.6)
where (δ1i, δ2i) ∈ {(0, 0), (0, 1), (1, 0), (1, 1)}. Then under the copula framework (2.1), with a
FLM for the genetic effect, the joint survival function can be further written as
S(y1i, y2i) = Cη(exp
(
−
∫ y1i
0
λ1i(t)dt
)
, exp
(
−
∫ y2i
0
λ2i(t)dt
)
),
where λki(t) can be modeled by either (2.4) or (2.5), depending whether to smooth the GVF
Gi(u) or not.
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2.3.1 Generalized score test. We are interested in testing whether a gene region is as-
sociated with the disease progression, after adjusting for other risk factors. To accomplish
this, we separate the entire parameter θ into two parts: θ1, the parameter of interest; and
θ2, the nuisance parameter. Under the bivariate FLM-based copula model, we have θ1 = γ,
which is the gene/region effect, and θ2 = (β, η, λ10, λ20) contains the rest of parameters in
the likelihood. Then the null hypothesis can be formulated as
H0 : θ1 = (γ1, . . . , γBγ )
′ = 0 and θ2 is arbitrary. (2.7)
In GWAS, score test is typically preferred than other likelihood-based tests due to its
computational advantage. This is because only one null model (without any SNP) needs to
be fitted for the score test. We now describe the generalized score test under the FLM-based
copula framework for testing (2.7).
Assume θˆ0 = (θ1 = 0, θ2 = θˆ20) is the restricted maximum likelihood estimate (MLE)
of θ under the restriction of θ1 = 0, solved from the joint likelihood under (2.6), then the
corresponding score function is
U(θˆ0) =
∂
∂θ
logL(θ;D)
∣∣∣∣
θ=θˆ0
= (U ′1(θˆ0), U
′
2(θˆ0))
′ = (U ′1(θˆ0), 0
′)′,
where Ul(·) = ∂ logL/∂θl, l = 1, 2, and the Fisher’s information is
I(θˆ0) = −E
[
∂2
∂θT∂θ
logL(θ;D)
]∣∣∣∣
θ=θˆ0
=
I11(θˆ0) I12(θˆ0)
I21(θˆ0) I22(θˆ0)
 ,
with I11, I12, I21 and I22 being partitions of the information matrix I by θ1 and θ2.
Finally, by using the observed information matrix J (θˆ0) (J (θ) = −∂2 logL(θ;D)∂θ′∂θ ) to approx-
imate I(θˆ0), the generalized score statistic for testing (2.7) can be constructed as follows
Qs = U
′
1(θˆ0)J 11(θˆ0)U1(θˆ0),
where U ′1(θˆ0) is a Bγ × 1 vector and J 11 = (J −1)11 = (J11 − J12J −122 J21)−1 is a Bγ × Bγ
matrix.
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We can use similar numerical approximation techniques as proposed in Sun et al. (2019),
such as using the Richardson’s extrapolation to approximate the score function and observed
information matrix. The score test statistic asymptotically follows a χ2 distribution with Bγ
degrees of freedom under the null.
2.3.2 Likelihood ratio test. Different from the GWAS case, where the computational
efficiency is a key factor for deciding the test procedure, we have a lot less number of tests
in the gene-based test situation (∼ 20K genes vs millions of variants in GWAS). Therefore,
an alternative approach to the generalized score test is to perform the likelihood ratio test
(LRT). Specifically, the LRT statistic can be written as
Ql = −2(logL(θˆ0)− logL(θˆ)),
where L(θˆ) is the the unrestricted maximum likelihood value of the joint likelihood and
L(θˆ0) is the restricted maximum likelihood under H0. Ql also asymptotically follows a χ
2
distribution with degrees of freedom Bγ.
3. Simulation Study
In this section, we performed simulation studies to evaluate the performance of the proposed
method in terms of type-I error control and power. Two scenarios were considered: (1) a
mixture of common (MAF> 5%) and rare causal variants (MAF∈ [1%, 5%]); (2) all causal
variants are rare (MAF ∈ [1%, 5%]). We reported the results of copula-based functional
regression model using score test (Cop-Score) and LRT (Cop-LRT), and compared with the
following methods: (a) FLM under Cox PH assuming the bivariate traits are independent
(Cox-Ind), or (b) using the “robust sandwich estimator” for the variance-covariance matrix
(Cox-Rst), (c) univariate FLM under Cox PH (Cox-FLM), (d) Burden test, and (e) SKAT
test. The last two methods are from R package {seqMeta} (Voorman et al. 2016). To evaluate
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the performance of univariate methods (c)-(e), only one margin (left eye) from simulated data
was used.
3.1 Data generation
In our simulation, 100 genotype datasets, each with a sample size 1000 were simulated.
For each genotype set, 1000 phenotype datasets of bivariate survival times and one non-
genetic covariate were generated, which lead to a total of 100,000 datasets. Similar simulation
approach was used in Chen et al. (2014), which has been shown to produce valid comparisons
between methods.
Genetic data were generated from European ancestry of 10,000 haplotypes covering 1Mb
regions, simulated by Yun Li at the University of North Carolina (Fan et al. 2016). Calibrated
coalescent model as programmed in COSI was used to generate the haplotypes with linkage
disequilibrium (LD) information (Schaffner et al. 2005). With 10,000 haplotypes, we chose a
genetic region of length 6 Kb and 30 Kb for all and rare only variants scenarios, respectively.
For both scenarios, the regions contain around 20 variants. A random mating technical was
then applied to generate genetic information for 1000 subjects.
Bivariate time-to-event phenotypes were generated from a Clayton Weibull model as fol-
lows. Recall that under a copula model S(t1, t2) = Cη(S1(t1), S2(t2)), U = S1(T1), V = S2(T2)
each follows a uniform distribution U [0, 1]. Define Wv(u) = h(u, v) = P (U 6 u|V =
v) = ∂Cη(u, v)/∂v. First, we generated vi and wi from two independent standard uniform
distributions. Then let wi = h(ui, vi)(= Cη(ui, vi)/∂vi) and solve for ui from the inverse
function h−1. Finally, we obtained two survival times t1i and t2i from S−11 (ui) and S
−1
2 (vi)
respectively. The scale and shape parameters in the baseline Weibull distribution were set to
be λ = 0.1 and k = 2, same for both margins. For Clayton copula, the dependence strength
is determined by Kendall’s τ . Here we chose τ = 0.05, 0.4 and 0.8 to represent weak to strong
dependence between two marginal survivals. Censoring times c1i and c2i were generated from
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uniform distribution U(0, C) with C chosen to yield a 50% censoring rate. The non-genetic
covariate Xng,k(k = 1, 2) was generated from N(6, 2
2).
For type-I error control simulations, we assumed there is neither a genetic effect (γ(u) =
0) nor a non-genetic effect (β = 0). The type-I error was evaluated at various α levels:
0.05, 0.01, 10−3 and 10−4, respectively. For power analysis, we generated data to evaluate
both homogeneous genetic effects (genes with effects in the same direction) and heterogeneous
genetic effects (genes with effects in opposite directions). Similar as in (Fan et al. 2016), the
effect size for each causal variant (i.e., γ(u)) was chosen to be a constant that depends on
MAF: c |log10MAF |
2
, where c = 0.4, 0.3, 0.25 for scenarios with 10%, 20% and 30% of causal
variants in a given region, respectively.
3.2 Type-I error
We chose B-splines with 5 basis for all FLM methods. Table 1 presents the type-I error results
for the scenario with both common and rare variants. As expected, the independent Cox FLM
(Cox-Ind) yields inflated type-I errors and the inflation becomes more severe when data
are more dependent. With robust variance-covariance estimates, Cox-Rst still shows some
inflation in type-I error, especially under small α tail. Similar observations were found in
testing single variants with bivariate survival outcomes (Sun et al. 2019). Within the copula-
based FLM, both the score test (Cop-Score) and LRT (Cop-LRT) produce satisfactory-
controlled type- I errors.
[Table 1 about here.]
Table 2 presents the type-I error results for testing regions that contain only rare variants
(MAF ∈ [1%, 5%]). The overall performance is similar to the all variants scenario. The
inflation in the robust Cox model (Cox-Rst) is slightly more compared to the all variants
scenario, which is also consistent with the observation in Sun et al. (2019).
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[Table 2 about here.]
3.3 Empirical power
[Figure 1 about here.]
Figure 1 illustrates the power bars over different dependence levels and genetic effect sizes
for the mixture of common and rare variants scenario. Given the independent Cox model
cannot control type-I error at all, we did not include it in the power analysis. Overall, the
bivariate approaches produce higher power than any univariate approach. When the two
margins are highly dependent, the copula-based tests achieve higher power than the Cox-
Rst method. In general, the score and LRT tests provide similar results, which is as expected.
We also notice that, when there are heterogeneous genetic effects in a region (the bottom
panel), the power of burden test drops significantly.
Figure 2 shows the power analysis for the rare variants only scenario. It can be seen that
when only rare variants are considered, the univariate Cox FLM model (CoxFLM) does not
perform well as compared to other univariate methods, which is different from the case when
all variants are included. In contrast, SKAT maintains relatively high power for both cases of
homogeneous and heterogeneous genetic effects. Burden test shows comparable results when
the genetic effects are homogeneous, and the power drops when the effects are heterogeneous.
As for the bivariate methods, Cox-Rst model performs well when the dependence between
two margins is weak, but as the dependence increases, the power tends to decrease. Overall,
our copula-based bivariate methods achieve high power in all the scenarios.
[Figure 2 about here.]
14 Biometrics, xxxx xxxx
4. Application on AREDS data
4.1 Examination on the Reported Four Regions from Previous Publications
AREDS is a major clinical trial sponsored by the National Eye Institute to study the risk
factors for AMD progression (Age-Related Eye Disease Study Research Group 1999). The
bilateral nature makes it a perfect example for the demonstration of our proposed methods.
Over the past few years, many case-control GWAS studies have identified multiple SNPs
associated with AMD susceptibility (Chen et al. 2010; Fritsche et al. 2013, 2016) and
recent genetic studies on AMD progression identified SNPs that are associated with disease
progression (Ding et al. 2017; Yan et al. 2018). Table 3 presents top four genetic regions
which contain SNPs associated with AMD risk identified by the traditional single-marker
GWAS in Fritsche et al. (2016). These four regions were also reported to be top gene regions
containing variants associated with AMD progression in Yan et al. (2018). Therefore, we first
examined these four candidate regions specifically. Location of gene regions were extracted
based on GRCh37/hg19 assembly from UCSC Genome Browser. Variants within +/− 5Kb
of the region boundary were included in the analysis.
We included all Caucasian participants with neither eye progressed at the time of enroll-
ment into the study. For bivariate approaches, time-to-progression was calculated for each
eye of each patient. For univariate approaches, only left-eye data were used. A total of 2296
subjects were included in the analysis. The baseline age and disease severity score (on a
continuous scale ranging from 1 to 8) were included in the regression part of the model as
the non-genetic risk factors.
[Table 3 about here.]
We fitted a Clayton copula with Weibull margins to perform the gene-based analysis. B-
spline was used to smooth the genetic effect function. The number of basis is usually decided
based upon the sample size (or equivalently, the total number of events in survival analysis)
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or through cross validations. In our analysis, we examined three different number of bases:
5, 6 and 7. A mixture of common (MAF> 5%) and rare causal variants (MAF∈ [1%, 5%])
were tested. Similar to the simulation studies, we compared our proposed copula-based FLM
score test to the Cox robust model, the univariate Cox FLM, SKAT and burden test. Since
the copula-based FLM LRT has shown virtually identical results to the score test in the
simulations, we did not include it here.
Table 4 presents p-values of testing the four candidate gene regions that contain both
common and rare variants. The bivariate approaches, i.e., copula-based FLM (Cop-Score)
and robust Cox (Cox-Rst) identify CFH, C2-CFB-SKIV2L and ARMS2 regions at the
significance level of 0.05, with smaller p-values produced from Cop-Score. For the C3 region,
both bivariate methods have shown marginal significance. Due to ignoring data from the
right eye, none of the univariate approaches identifies all four gene regions, with the best
case scenario, SKAT, identifying three gene regions except the ARMS2 region. The univariate
Cox-FLM identifies two gene regions: CFH and ARMS2, while the burden test only shows
that CFH is significant. Note that for the three approaches that involve FLM, varying the
number of basis from 5 to 7 produces similar results in this data set.
Figure 3 presents the estimated genetic effect functions for the four gene regions under the
six B-spline bases scenario. The CFH shows the largest effect size with most of the positions
having a negative effect, and it explains the smallest p-values obtained from the FLM based
methods for this region. Since most of the effects seem to be homogeneous in the CFH region,
the burden test maintains the power by providing a p-value as small as 7.11×10−4. For other
regions, they all show heterogeneous effects with some positions having positive effects while
others having negative effects, so the burden test loses power under these situations. The
ARMS2 and C2 regions both show reasonable amount of effects and thus the copula-based
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FLM method has detected these two regions to be significant. The flat curve presented by
the C3 region also explains the marginal significance from the copula-FLM approach.
[Table 4 about here.]
[Figure 3 about here.]
4.2 Genome-wide Association Study
We then applied the copula-based model on the whole genome to search for top gene regions
that are associated with the AMD progression. Again, all gene regions were extracted based
on GRCh37/hg19 assembly from UCSC Genome Browser and those with less than 10 SNPs
were excluded from the analysis. In total we analyzed 22,747 gene regions.
Table 5 presents p-values of top gene regions identified by the proposed copula-FLM
approach, at the α level of 1.0 × 10−5. All methods have generated consistent p-values for
these regions, with copula-FLM producing the smallest p-values. The last column presents
the number of significant SNPs identified by the traditional single-SNP-based clayton copula
model under the nominal α level of 0.05. In addition to the CFH and ARMS2 regions,
DLGAP2-AS1, GABRA5, CLEC4GP1 and HAL-C regions all have more than 30% of the
SNPs to be associated with the AMD progression in a less stringent sense, which explains
the reason why they were not among the top genes list in the single-SNP-based GWAS
studies but were identified in a gene-based analysis. Among these gene regions, gene HLA-C
has been shown to have association with AMD in combination with inhibitory Killer-cell
immunoglobulin-like receptors on natural killer (NK) cells (Goverdhan et al. 2005).
[Table 5 about here.]
5. Conclusion and Discussion
In this work, we have developed a new gene-based association analysis method for bivari-
ate time-to-event data using the functional linear model under the copula framework. We
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implemented our proposed methods in R. The key functions can be found in the GitHub
https://github.com/yingding99/CopulaFLM. This approach has also been added to a newly
developed R package {CopulaCenR}. On one hand, the genetic effect can be viewed as a
function of the physical positions of variants under the functional linear model. On the
other hand, the copula model can effectively handle the correlation between two margins.
Combining the FLM with the copula framework fully takes the advantage of both methods
for detecting gene regions that are significantly associated with the progression of bilateral
diseases. The great advantage of the proposed copula-FLM model is that the genetic ef-
fects are treated as a function of the physical positions of the variants. Therefore, the LD
information can be directly taken account in this method.
Extensive simulation studies were performed to evaluate the type-I error rates and power
performance of our method. Both the score test and the LRT from our copula FLM model
control type-I error well. For the power analysis, our bivariate tests show great advantage
by utilizing all available data without collapsing them into the subject level.
We successfully applied our method on AREDS data at four known AMD risk gene
regions and obtained consistent findings. Through the genome-wide study, nine gene regions
were found to be significantly associated with the disease progression, where PCDH9-AS4,
DLGAP2-AS1, LINC00476, GABRA5, CLEC4GP1, HLA-C and SULF1 are novel regions.
The findings from this research provide new perspectives on the genetic underpinning of
AMD progression, which will be valuable to establish novel and reliable predictive models
for AMD progression. The proposed method is useful for genome-wide association studies of
any bilateral disease with survival traits to identify disease susceptible gene regions.
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Figure 1. Empirical power analysis for 1000 gene regions that contain both common and
rare variants at various dependence strength levels
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Figure 2. Empirical power analysis for 1000 gene regions that contain only rare variants
at various dependence strength levels
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Figure 3. Estimated genetic effect functions for four candidate gene regions from the
copula-FLM approach with six number of B-spline basis
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Table 1
Type-I error at various dependence levels from Clayton copula with Weibull margins for testing gene regions that
contain both common and rare variants.
Bivariate FLM Univariate
τ α level Cop-Score Cop-LRT Cox-Ind Cox-Rst CoxFLM Burden SKAT
0.05
0.05 0.0547 0.0524 0.0673 0.0626 0.0523 0.0492 0.0494
0.01 0.0114 0.0102 0.0152 0.0150 0.0104 0.0105 0.0099
0.001 0.0014 0.0012 0.0020 0.0022 0.0012 0.0010 0.0012
0.0001 0.00015 0.00010 0.00033 0.00047 0.00018 0.00010 0.00009
0.4
0.05 0.0527 0.0522 0.2119 0.0653 0.0515 0.0495 0.0504
0.01 0.0105 0.0103 0.0832 0.0162 0.0104 0.0099 0.0099
0.001 0.0011 0.0011 0.0214 0.0025 0.0012 0.0010 0.0011
0.0001 0.00015 0.00012 0.00521 0.00047 0.00010 0.00012 0.00009
0.8
0.05 0.0534 0.0521 0.3293 0.0628 0.0526 0.0500 0.0511
0.01 0.0110 0.0105 0.1644 0.0159 0.0107 0.0097 0.0101
0.001 0.0011 0.0011 0.0594 0.0021 0.0010 0.0011 0.0012
0.0001 0.00012 0.00014 0.02103 0.00042 0.00010 0.00012 0.00013
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Table 2
Type-I error at various association levels from the Clayton copula with Weibull margins for testing gene regions that
contain only rare variants.
Bivariate FLM Univariate
τ α level Cop-Score Cop-LRT Cox-Ind Cox-Rst CoxFLM Burden SKAT
0.05
0.05 0.0539 0.0540 0.0690 0.0677 0.0516 0.0500 0.0490
0.01 0.0115 0.0118 0.0160 0.0175 0.0105 0.0099 0.0094
0.001 0.0011 0.0011 0.0021 0.0035 0.0010 0.0010 0.0009
0.0001 0.00014 0.00011 0.00030 0.00135 0.00010 0.00009 0.00010
0.4
0.05 0.0541 0.0537 0.2151 0.0674 0.0521 0.0505 0.0499
0.01 0.0113 0.0110 0.0855 0.0173 0.0110 0.0101 0.0099
0.001 0.0013 0.0012 0.0226 0.0032 0.0011 0.0011 0.0008
0.0001 0.00012 0.00012 0.00628 0.00063 0.00010 0.00011 0.00014
0.8
0.05 0.0534 0.0517 0.3305 0.0646 0.0519 0.0502 0.0502
0.01 0.0110 0.0101 0.1671 0.0151 0.0112 0.0104 0.0103
0.001 0.0011 0.0010 0.0609 0.0022 0.0012 0.0010 0.00091
0.0001 0.00012 0.00006 0.02122 0.00035 0.0001 0.00008 0.00010
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Table 3
Four candidate gene regions from published single variant case-control GWAS AMD studies
Region Chr StartPos** EndPos** Number of SNPs
CFH 1 196,621,008 196,716,634 281
C2-CFB-SKIV2L 6 31,65,562 31,937,532 250
ARMS2 regions* 10 124,134,094 124,274,424 541
C3 19 6,677,715 6,730,573 294
* PLEKHA1,MIR3941,ARMS2,HTRA1
** Actural regions are selected with reference start and end pos +/− 5K (hg19)
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Table 4
Results from different gene-based tests on four candidate regions (including both common and rare variants) using
the AREDS data
Bivariate FLM Univariate
Gene Chr basis # Cop-Score Cox-Rst CoxFLM Burden SKAT
5 6.79× 10−10 1.05× 10−7 3.82× 10−4
CFH 1 6 9.93× 10−10 1.43× 10−7 4.14× 10−4 7.11× 10−4 0.01
7 3.24× 10−9 3.56× 10−7 8.14× 10−4
5 2.02× 10−3 8.17× 10−3 0.13
C2-CFB-SKIV2L 6 6 3.74× 10−3 0.01 0.19 0.43 0.02
7 6.81× 10−3 0.02 0.23
5 5.40× 10−4 0.01 0.03
ARMS2 regions 10 6 8.06× 10−4 0.01 0.03 0.88 0.19
7 4.81× 10−5 5.91× 10−3 0.01
5 0.05 0.03 0.14
C3 19 6 0.05 0.04 0.15 0.77 1.37× 10−3
7 0.10 0.06 0.24
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Table 5
Top gene regions identified by GWAS on AREDS data using the copula-FLM approach
Gene Chr # of SNPs Cop-Score Cox-Rst CoxFLM # of Sig. SNP (%)*
CFH 1 281 9.93× 10−10 1.43× 10−7 4.14× 10−4 186 (66.2)
PCDH9-AS4 13 55 6.64× 10−8 4.21× 10−4 3.85× 10−3 9 (16.4)
DLGAP2-AS1 8 336 8.40× 10−7 7.53× 10−6 2.14× 10−5 229 (68.2)
ARMS2 10 51 2.07× 10−6 1.37× 10−3 1.91× 10−2 33 (64.7)
LINC00476 9 201 2.23× 10−6 3.41× 10−5 2.52× 10−2 57 (28.4)
GABRA5 15 168 2.59× 10−6 7.75× 10−6 6.18× 10−4 68 (40.5)
CLEC4GP1 19 75 3.23× 10−6 2.60× 10−4 4.61× 10−4 30 (40.0)
HLA-C 6 574 3.12× 10−6 3.85× 10−4 8.06× 10−4 187 (32.6)
SULF1 8 563 8.72× 10−6 4.91× 10−5 1.40× 10−3 75 (13.3)
* based on 0.05 alpha level
